ImmunityBio, Inc. IBRX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Other revenues | $337K+10.1% | $306K-52.1% | $639K+25.3% | $510K-9.4% | $563K-5.4% | |
| Product revenue, net | $140.64M+24.5% | $112.98M+37.9% | $81.92M+46.0% | $56.09M+82.9% | $30.66M+117% | |
| Revenue by Geography | ||||||
| Europe | $302K+8.6% | $278K-53.4% | $597K+31.2% | $455K-10.1% | $506K-4.7% | |
| U.S. | $140.68M+24.5% | $113.01M+37.9% | $81.96M+46.0% | $56.15M+82.8% | $30.72M+116% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ImmunityBio, Inc. break its business down?
- ImmunityBio, Inc. (IBRX) reports total revenue by product across 2 parts — Other revenues and Product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does ImmunityBio, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ImmunityBio, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
